"We have a history of losses and negative cash flows from operating activities, and we may not be able to attain or to maintain profitability or positive cash flows from operating activities in the future".
The human penis frequently encounters erectile dysfunction (ED), defined as inability either to attain or to maintain rigid erection for satisfactory intercourse [ 6].
According to the definitions of the First International Consultation on erectile dysfunction (ED), co-sponsored by the World Health Organization (WHO), ED is considered "the consistent or recurrent inability to attain and/or to maintain a penile erection sufficient for sexual performance" (Jardin et al. 2000).
Efficacy parameters for sildenafil in 11 double-blind, placebo controlled, pre-marketing studies included the International Index of Erectile Function (IIEF) erectile function domain score and especially the questions 3 and 4 (ability to attain and ability to maintain an erection sufficient for intercourse respectively) as well as the general efficacy question (GEQ).
These reports could reassure them that their average BP was within target (<135/85 mm Hg) or tell them that their BP average had improved on the last report but had not attained the target and to maintain current therapy, or that their BP was not at target and that they should contact their clinician.
However, the prepared samples do not attain sufficient retention property to maintain their hydrophilicity.
However, in a small group of patients with cardiocirculatory failure, recommended standard therapy alone is not sufficient to attain a MAP necessary to maintain perfusion of an altered microcirculation.
To the extent that the goal of management is both to attain A1C goals and to maintain glucose levels similar to those of the DPP patients who had normal glucose levels when OGTTs were performed (36), some home glucose monitoring will likely be needed to determine whether therapy in individual patients needs to be directed toward fasting versus postprandial glucose levels.
In Studies B and C, patients self-titrated doses of MS or MS/DM, based on stable doses of MS or other opioids attained during Run-in periods, to maintain pain relief; percentage changes from baseline in MS (or MS-equivalent) doses were compared.
The model assumed that treated patients who had attained an ACR 20, continued to maintain this improvement while on therapy with a specific biologic agent.
